ARTICLE | Company News
Sygnis restructures
October 30, 2010 12:55 AM UTC
Sygnis Pharma AG (Xetra:LIO) will restructure and reduce headcount by 19 (37%) to 32 to save cash. Sygnis said it will focus on AX200, an endogenous granulocyte colony-stimulating factor (G-CSF) prote...